SANA (STOCKS)
Sana Biotechnology, Inc. Common Stock
$2.800000
+0.120000 (+4.48%)
Prev close: $2.680000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Steven D. Harr
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $794.52M
- Employees
- 194
- P/E (TTM)
- -2.85
- P/B (TTM)
- 6.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.17 | $-0.17 | +0.0030 | +1.73% |
|
Dec 2025 (Q4)
|
$-0.21 | $-0.14 | -0.0745 | -54.98% |
|
Sep 2025 (Q3)
|
$-0.16 | $-0.18 | +0.0235 | +12.81% |
|
Jun 2025 (Q2)
|
$-0.21 | $-0.21 | +0.0010 | +0.47% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $248.30M |
| Research and Development | $123.51M |
| Other Operating Expenses | $124.79M |
| Operating Income/Loss | -$248.30M |
| Income/Loss From Continuing Operations After Tax | -$241.99M |
| Income/Loss From Continuing Operations Before Tax | -$241.99M |
| Net Income/Loss | -$241.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$241.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$241.99M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.93 |
| Diluted Earnings Per Share | -$0.93 |
| Basic Average Shares | 783,413,000 |
| Diluted Average Shares | 783,413,000 |
| Assets | $373.59M |
| Current Assets | $111.69M |
| Noncurrent Assets | $261.90M |
| Fixed Assets | $25.67M |
| Intangible Assets | $59.20M |
| Other Non-current Assets | $177.04M |
| Liabilities | $254.35M |
| Current Liabilities | $86.27M |
| Accounts Payable | $2.12M |
| Wages | $7.58M |
| Other Current Liabilities | $76.56M |
| Noncurrent Liabilities | $168.09M |
| Equity | $119.24M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $119.24M |
| Liabilities And Equity | $373.59M |
| Net Cash Flow From Operating Activities | -$132.55M |
| Net Cash Flow From Operating Activities, Continuing | -$132.55M |
| Net Cash Flow From Investing Activities | -$7.40M |
| Net Cash Flow From Investing Activities, Continuing | -$7.40M |
| Net Cash Flow From Financing Activities | $127.62M |
| Net Cash Flow From Financing Activities, Continuing | $127.62M |
| Net Cash Flow | -$12.33M |
| Net Cash Flow, Continuing | -$12.33M |
| Comprehensive Income/Loss | -$241.99M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$241.99M |
| Other Comprehensive Income/Loss | -$42.15M |